CN109633147A - The detection method of fluoquinolone constituents in a kind of fresh royal jelly - Google Patents

The detection method of fluoquinolone constituents in a kind of fresh royal jelly Download PDF

Info

Publication number
CN109633147A
CN109633147A CN201811496858.6A CN201811496858A CN109633147A CN 109633147 A CN109633147 A CN 109633147A CN 201811496858 A CN201811496858 A CN 201811496858A CN 109633147 A CN109633147 A CN 109633147A
Authority
CN
China
Prior art keywords
sample
solution
royal jelly
fluoquinolone
constituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811496858.6A
Other languages
Chinese (zh)
Inventor
张暘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hangzhou Kang Li Food Co Ltd
Original Assignee
Hangzhou Kang Li Food Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Kang Li Food Co Ltd filed Critical Hangzhou Kang Li Food Co Ltd
Priority to CN201811496858.6A priority Critical patent/CN109633147A/en
Publication of CN109633147A publication Critical patent/CN109633147A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to the detection methods of fluoquinolone constituents in a kind of fresh royal jelly of royal jelly detection technique field, including sample pre-treatments: extraction-purification-supernatant processing;Sample detection: it is detected using the detection kit of fluorine promise quinoline ketone drug.The application is intended to provide a kind of detection method of fluoquinolone constituents that pre-treatment is easy to operate.

Description

The detection method of fluoquinolone constituents in a kind of fresh royal jelly
Technical field
The present invention relates to a kind of inspections of fluoquinolone constituents in royal jelly detection technique field more particularly to fresh royal jelly Survey method.
Background technique
Honey is the necessary all kinds of nutriments of human body to be rich in, such as glucose, fructose, ammonia from honeybee acquisition nectar Base acid, enzyme, mineral and antioxidant etc., are important wholefood.Royal jelly is the lingual gland and mandibular gland point by worker bee The compounding substances secreted have extraordinary health care and medical value.However, in actual production honeybee be easy by bacterium, fungi, Viral and external parasitic infecting for mite class and cause disease.Controlling and treat these disease usual ways is Direct-fed veterinary drug Or veterinary drug is sprayed in honeycomb, it is thus possible to lead to the residue of veterinary drug problem in the bee products such as honey and royal jelly, to consumption Person causes potential threat.
Quinolone drugs is each commonly used to prevention and treatment and treatment in beekeeping as a kind of common antibiotics class veterinary drug Class bacterial disease can especially effectively prevent bee numbers caused by American foul brood and reduce and honey output drop It is low.
Currently, reporting the detection method of quinolones medicament relict in honey or royal jelly in some documents, mainly have Liquid chromatography and Liquid Chromatography-Tandem Mass Spectrometry, because Liquid Chromatography-Tandem Mass Spectrometry detection limit is low, sensitivity and accuracy High and be widely used, it is also the prescriptive procedure in China's honey and royal jelly.Pre-treating method mostly uses solid phase extraction techniques, Because it is required respectively by some column processes such as purification, concentration, complicated for operation, time-consuming and laborious, sensitivity and poor repeatability.Mesh Before, it is few can simple, quick sample-pretreating method for detecting quinolones medicament relict in royal jelly.
Summary of the invention
The purpose of the present invention is to provide a kind of detection methods of fluoquinolone constituents in fresh royal jelly, before having sample Handle simple, quick advantage.
Above-mentioned purpose of the invention has the technical scheme that
The detection method of fluoquinolone constituents in a kind of fresh royal jelly, including following detecting step,
(1) sample pre-treatments:
Step 1: extracting, weigh 2g fresh royal jelly sample into 50ml centrifuge tube, 5.0ml acetic acid zinc solution is added in centrifuge tube 5min sample dissolution is shaken, 10ml ethyl acetate is added into sample solution, after 10min is extracted in concussion, 1.0g sodium chloride is added With 4.0g anhydrous zinc sulfate, after whirling motion 1min, 5min is shaken, is centrifuged 5min under the conditions of 8000-10000rpm;
Step 2: purification accurately pipettes supernatant 5.0ml in the 15 mL centrifuge tubes equipped with 500 mg PSA, oscillation 5 Min, 6000rpm are centrifuged 5 min, and 1.0 mL of supernatant is taken to be dried with nitrogen at 30 DEG C in 2 mL centrifuge tubes;
Step 3: after supernatant is dried with nitrogen, 500 μ L sodium carbonate liquor (0.1 mM, pH=10.5) whirlpools being added into centrifuge tube Inula is molten, adds 500 μ L dansyl Cls-acetone soln (1.0 mg/mL) and is vortexed at once mixing;In 60 DEG C of 15 min of heating; After derivatization, it is placed in 4 DEG C of 10 min of refrigerator cold-storage;Final sample solution crosses 0.2 μm of filter membrane;
Sample detection: it is detected using the detection kit of fluorine promise quinoline ketone drug.
Implement above-mentioned technical proposal, royal jelly sample mesostroma is complicated, contains protein, fat, lactose, organic acid and ammonia The chaff interferents such as base acid, effective degreasing, deproteinization directly determine the efficiency extracted.And in the process of dissolution royal jelly sample In, the effect of pure water and acetic acid zinc solution dissolved matrix is compared, is occurred more when instrument analysis results show pure water as lytic agent More impurity Interference Peaks, influence the accurate quantitative analysis of target compound;And when using acetic acid zinc solution as lytic agent, because it is mentioned The high concentrated acid radical ion of confession can seize the spray layer of protein surface, protein micelle " dehydration ", and then condense and precipitate It is precipitated, on the other hand, protein is minimum in the solubility of isoelectric point, and acid pH provided by zinc acetate buffer solution is close to bee The isoelectric point of most of protein plays the effect of decontamination substrate so that also accelerating protein is precipitated precipitating in royal jelly.
In addition, sodium chloride and anhydrous zinc sulfate are added into solution can play salting out, ionic strength is improved, is deepened Sediment and supernatant separation, and increase the extraction efficiency to target compound.
The PSA of addition can remove organic acid, fatty acid, certain pigments and carbohydrate isopolarity matrix in sample in extract Ingredient selects PSA as scavenging material, easy to operate, and for organic acid, fatty acid, certain pigments and carbohydrate isopolarity base The processing of matter is more thorough.
And the sulfonyl of dansyl Cl can and the phenolic hydroxyl group of quinolones hormone react and generate the easily combination that ionizes Object increases the sensitivity of detection.
The detection of fluoquinolone constituents in the detection kit detection fresh royal jelly of fluorine promise quinoline ketone drug is finally selected, It is simple to operate.
Test sample is just directly obtained by extraction-purification-supernatant processing during whole operation, compared with traditional benefit It is simpler with the operating method of solid-phase extraction column.
Further, the detection method of the detection kit of the fluoroquinolones includes the following steps,
S1. fluoroquinolones kit is returned and is warmed to room temperature;
S2. it takes out and needs the microwell plate of quantity to get all the ready and be inserted on micropore frame, record sample and standard items correspond to micropore and by suitable Sequence number, each sample and gauge orifice do 2 hole parallel tests;
S3. plus standard items/sample, 50 μ L Norfloxacin standard solution of absorption draw 50 μ L sample solution into corresponding micropore In remaining micropore, draws 75 μ L Norfloxacin monoclonal antibodies and thyroid peroxidase marks the mixed of sheep anti mouse antiantibody Closing liquid, gently oscillation mixes in each micropore, reacts 30min in cover board membrane cover plate 25 DEG C of light protected environments of postposition;
S4. board-washing, open cover board film, liquid in hole is dried, with 250 hole μ L/ of wash operating solution, sufficiently washing three times, every time It is spaced 10s, is patted dry with blotting paper;
S5. it develops the color: substrate colour developing 50 hole μ l/ of A liquid is added, substrate colour developing 50 hole μ l/ of B liquid, gently oscillation mixes, with cover board membrane cover 15min is reacted in 25 DEG C of light protected environments of plate postposition;
S6. it measures, 50 hole μ L/ of terminate liquid is added, gently concussion mixes, and sets microplate reader at 450nm, measures every hole OD value.
Implement above-mentioned technical proposal, is detected using the detection method of the detection kit of fluoroquinolones, most OD value is determined eventually, and the content of fluorine quino ketone in royal jelly is obtained eventually by conversion.
Further, the H of the terminate liquid selection 2mol/L2SO4
Implement above-mentioned technical proposal, terminate liquid selection sulfuric acid can effectively inhibit the activity of enzyme, avoid the biological enzyme of survival It is influenced caused by testing result.
Further, the substrate developing solution A liquid is the citrate-phosphate two of the carbamide peroxide containing 0.4~0.6mmol/L Hydrogen sodium buffer solution, substrate develop the color B liquid for tetramethyl biphenyl amine aqueous solution.
Implement above-mentioned technical proposal, the substrate developing solution A and substrate developing solution B of selection, which can cooperate, increases reaction Sensitivity.
Further, the wash operating solution includes the PBS solution containing 0.05% Tween-20.
Implement above-mentioned technical proposal, Tween-20 has the part of oleophylic as surfactant, existing hydrophilic part, It is able to ascend clean level.
Further, the Norfloxacin standard solution is the storage for selecting ethyl acetate to be configured to 100ng/mL as solvent Liquid saves under the conditions of -20 DEG C.
Further, the preparation of the fluoroquinolones monoclonal antibody:
Animal immune: 8~10 week old Balb/c mouse are immunized in fluoroquinolones haptens and carrier protein couplet object;
Cell fusion and cloning: the mice spleen cell after being immunized is taken, with SP2/0 myeloma cell in fusion agent Macrogol 4000 Under the action of merge, screening obtain can stably excreting monoclonal antibody hybridoma cell strain;
The monoclonal hybridoma strain of fluoroquinolones is obtained through screening;The Monoclonal hybridomas of fluoroquinolones Cell strain can an unbounded quantity of generation fluoroquinolones specific antibody, which is for fluoroquinolones medicine Object, sensitivity reaches 0.1 μ g/L;
Hybridoma: being made the cell suspension of 1 × 109/ml by cell cryopreservation and recovery of frozen stock solution, long-term in liquid nitrogen It saves;
Cryopreservation tube is taken out when recovery, 37 DEG C of water-bath middling speeds is immediately placed in and melts, and after centrifugation removal frozen stock solution, moves into training in culture bottle It supports.
Implement above-mentioned technical proposal, the monoclonal hybridoma strain of fluoroquinolones can an unbounded quantity of generation fluorine Quinolone drugs specific antibody, for the antibody specificity for fluoroquinolones, sensitivity reaches 0.1 μ g/L. Entire preparation exploitativeness is strong.
Further, the preparation process of the thyroid peroxidase label sheep anti mouse antiantibody includes: by marker enzyme first Shape gland peroxidase and sheep anti mouse antiantibody are coupled to obtain thyroid peroxidase label using Euplotes woodruffi Sheep anti mouse antiantibody.
Implement above-mentioned technical proposal, Euplotes woodruffi is a kind of common homotype bi-functional cross-linking agent, passes through its two A aldehyde radical in conjunction with the amino of HRP and antibody protein, forms HRP- glutaraldehyde-Ab protein conjugates respectively.Prepare thyroid gland mistake Oxide enzyme marks the preparation process of sheep anti mouse antiantibody simple.
In conclusion the invention has the following advantages:
One, it selects zinc acetate as buffer, can speed up the wash-off precipitating of protein, decontamination substrate effect is obvious;
Two, using the operating method of the application, the process of pre-treatment is easy to operate.
Specific embodiment
1, the preparation of fluoroquinolones monoclonal antibody:
Animal immune: 8~10 week old Balb/c mouse are immunized in fluoroquinolones haptens and carrier protein couplet object;
Cell fusion and cloning: the mice spleen cell after being immunized is taken, with SP2/0 myeloma cell in fusion agent Macrogol 4000 Under the action of merge, screening obtain can stably excreting monoclonal antibody hybridoma cell strain;
The monoclonal hybridoma strain of fluoroquinolones is obtained through screening;
Cell cryopreservation and recovery: hybridoma is made 1 × 10 with frozen stock solution9The cell suspension of a/ml, it is long-term in liquid nitrogen It saves;
Cryopreservation tube is taken out when recovery, 37 DEG C of water-bath middling speeds is immediately placed in and melts, and after centrifugation removal frozen stock solution, moves into training in culture bottle It supports.
2, the preparation process of thyroid peroxidase label sheep anti mouse antiantibody includes: by marker enzyme thyroid gland peroxidating Object enzyme and sheep anti mouse antiantibody are coupled to obtain thyroid peroxidase label sheep anti mouse anti-using Euplotes woodruffi Body.
3, the concentration of Norfloxacin standard solution is respectively set to 0ng/mL, 0.125ng/mL, 0.5 ng/mL, 2.5ng/ mL、5ng/mL、12.5ng/mL。
Embodiment one
(1) fresh royal jelly sample pre-treatments:
Step 1: extracting, weigh 2g fresh royal jelly sample into 50ml centrifuge tube, 5.0ml acetic acid zinc solution is added in centrifuge tube 5min sample dissolution is shaken, 10ml ethyl acetate is added into sample solution, after 10min is extracted in concussion, 1.0g sodium chloride is added With 4.0g anhydrous zinc sulfate, after whirling motion 1min, 5min is shaken, is centrifuged 5min under the conditions of 8000rpm;
Step 2: purification accurately pipettes supernatant 5.0ml in the 15mL centrifuge tube equipped with 500mg PSA, vibrates 5min, 6000rpm is centrifuged 5min, and supernatant 1.0mL is taken to be dried with nitrogen at 30 DEG C in 2mL centrifuge tube;
Step 3: after supernatant is dried with nitrogen, 500 μ L sodium carbonate liquors (0.1 mM, pH=10.5) vortex being added into centrifuge tube It redissolves, adds 500 μ L dansyl Cls-acetone soln (1.0 mg/mL) and be vortexed at once mixing;In 60 DEG C of heating 15min;Spread out After biochemistry, it is placed in 4 DEG C of refrigerator cold-storage 10min;Final sample solution crosses 0.2 μm of filter membrane;
(2) it sample detection: is detected using the detection kit of fluorine promise quinoline ketone drug;
S1. fluoroquinolones kit is returned and is warmed to room temperature;
S2. it takes out and needs the microwell plate of quantity to get all the ready and be inserted on micropore frame, record sample and standard items correspond to micropore and by suitable Sequence number, each sample and gauge orifice do 2 hole parallel tests;
S3. plus standard items/sample, 50 μ L Norfloxacin standard solution of absorption draw 50 μ L sample solution into corresponding micropore In remaining micropore, draws 75 μ L Norfloxacin monoclonal antibodies and thyroid peroxidase marks the mixed of sheep anti mouse antiantibody Closing liquid, gently oscillation mixes in each micropore, reacts 30min in cover board membrane cover plate 25 DEG C of light protected environments of postposition;
S4. board-washing, open cover board film, liquid in hole is dried, with 250 hole μ L/ of wash operating solution, sufficiently washing three times, every time It is spaced 10s, is patted dry with blotting paper;
S5. it develops the color: substrate colour developing 50 hole μ l/ of A liquid is added, substrate colour developing 50 hole μ l/ of B liquid, gently oscillation mixes, with cover board membrane cover 15min is reacted in 25 DEG C of light protected environments of plate postposition;
S6. it measures, 50 hole μ L/ of terminate liquid is added, gently concussion mixes, and sets microplate reader at 450nm, measures every hole OD value.
Analysis of test results: the percentage absorptance of standard items or sample is equal to being averaged for the absorbance value of standard items or sample Value obtains the percentage absorbance of standard items or sample multiplied by 100% divided by the average value of the absorbance value of first standard items Value.Using standard items percentage absorptance as ordinate, using the logarithm of fluoroquinolones standard concentration (μ g/L) as abscissa, Draw canonical plotting.The percentage absorptance of sample is substituted into standard curve, is read corresponding to sample from standard curve Concentration is the actual concentrations of fluoroquinolones in sample multiplied by its corresponding extension rate.
Embodiment 2
Embodiment 2 is the difference from embodiment 1 is that centrifugal speed is 9000rpm/ in extraction process in the step 1 of sample pre-treatments min。
Embodiment 3
Embodiment 2 is the difference from embodiment 1 is that centrifugal speed is in extraction process in the step 1 of sample pre-treatments 10000rpm/min。
Experiment Data Records
Standard curve obtained in embodiment 1 is y=- 0.341x+0.998
The calculation formula of the residual quantity of fluoquinolone
The residual quantity of fluoquinolone in X- sample, unit are ng/kg (μ g/kg);
C- blood concentration norfloxacin from the sample obtained on standard working curve, unit are nanograms per milliliter (ng/ml);
The final constant volume of V- sample solution, unit are milliliter (mL);
Final sample mass representated by m- sample solution, unit are gram (g).
The testing result of the residual quantity of 1 embodiment 1-3 fluoquinolone of table.
Project Embodiment 1 Embodiment 2 Embodiment 3
Lower limit of measurement μ g/kg 2.5 2. 5 2.5
Pitch-based sphere is 2.5 μ g/kg, and fluoquinolone rate of recovery range is 70%~93%;
Pitch-based sphere is 5.0 μ g/kg, and fluoquinolone rate of recovery range is 75%~97%;
Pitch-based sphere is 10.0 μ g/kg, and fluoquinolone rate of recovery range is 74%~90%;
On 2.5 μ g/kg, 5.0 μ g/kg and 10.0 μ g/kg pitch-based spheres, relative standard deviation (RSD) is 4.0%~6.0%.

Claims (8)

1. the detection method of fluoquinolone constituents in a kind of fresh royal jelly, which is characterized in that including following detecting step,
(1) sample pre-treatments:
Step 1: extracting, weigh 2g fresh royal jelly sample into 50ml centrifuge tube, 5.0ml acetic acid zinc solution is added in centrifuge tube 5min sample dissolution is shaken, 10ml ethyl acetate is added into sample solution, after 10min is extracted in concussion, 1.0g sodium chloride is added With 4.0g anhydrous zinc sulfate, after whirling motion 1min, 5min is shaken, is centrifuged 5min under the conditions of 8000-10000rpm;
Step 2: purification accurately pipettes supernatant 5.0ml in the 15 mL centrifuge tubes equipped with 500mg PSA, vibrates 5min, 6000rpm is centrifuged 5min, and 1.0 mL of supernatant is taken to be dried with nitrogen at 30 DEG C in 2 mL centrifuge tubes;
Step 3: after supernatant is dried with nitrogen, 500 μ L sodium carbonate liquors being added into centrifuge tube and are vortexed and redissolve, add 500 μ L Dansyl Cl-acetone soln is vortexed mixing at once;In 60 DEG C of heating 15min;After derivatization, it is placed in 4 DEG C of refrigerator cold-storages 10min;Final sample solution crosses 0.2 μm of filter membrane;
(2) it sample detection: is detected using the detection kit of fluorine promise quinoline ketone drug.
2. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute The detection method for stating the detection kit of fluoroquinolones includes the following steps,
S1. fluoroquinolones kit is returned and is warmed to room temperature;
S2. it takes out and needs the microwell plate of quantity to get all the ready and be inserted on micropore frame, record sample and standard items correspond to micropore and by suitable Sequence number, each sample and gauge orifice do 2 hole parallel tests;
S3. plus standard items/sample, 50 μ L Norfloxacin standard solution of absorption draw 50 μ L sample solution into corresponding micropore In remaining micropore, draws 75 μ L Norfloxacin monoclonal antibodies and thyroid peroxidase marks the mixed of sheep anti mouse antiantibody Closing liquid, gently oscillation mixes in each micropore, reacts 30min in cover board membrane cover plate 25 DEG C of light protected environments of postposition;
S4. board-washing, open cover board film, liquid in hole is dried, with 250 hole μ L/ of wash operating solution, sufficiently washing three times, every time It is spaced 10s, is patted dry with blotting paper;
S5. it develops the color: substrate colour developing 50 hole μ l/ of A liquid is added, substrate colour developing 50 hole μ l/ of B liquid, gently oscillation mixes, with cover board membrane cover 15min is reacted in 25 DEG C of light protected environments of plate postposition;
S6. it measures, 50 hole μ L/ of terminate liquid is added, gently concussion mixes, and sets microplate reader at 450nm, measures every hole OD value.
3. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute State the H of terminate liquid selection 2mol/L2SO4
4. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute State the citrate-phosphate sodium dihydrogen buffer solution that substrate developing solution A liquid is the carbamide peroxide containing 0.4~0.6mmol/L, substrate Colour developing B liquid is tetramethyl biphenyl amine aqueous solution.
5. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute Stating wash operating solution includes the PBS solution containing 0.05% Tween-20.
6. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute Stating Norfloxacin standard solution is the storing liquid for selecting ethyl acetate to be configured to 100ng/mL as solvent, under the conditions of -20 DEG C It saves.
7. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute State the preparation of fluoroquinolones monoclonal antibody:
Animal immune: 8~10 week old Balb/c mouse are immunized in fluoroquinolones haptens and carrier protein couplet object;
Cell fusion and cloning: the mice spleen cell after being immunized is taken, with SP2/0 myeloma cell in fusion agent Macrogol 4000 Under the action of merge, screening obtain can stably excreting monoclonal antibody hybridoma cell strain;
The monoclonal hybridoma strain of fluoroquinolones is obtained through screening;
Hybridoma: being made the cell suspension of 1 × 109/ml by cell cryopreservation and recovery of frozen stock solution, long-term in liquid nitrogen It saves;
Cryopreservation tube is taken out when recovery, 37 DEG C of water-bath middling speeds is immediately placed in and melts, and after centrifugation removal frozen stock solution, moves into training in culture bottle It supports.
8. the detection method of fluoquinolone constituents in a kind of fresh royal jelly according to claim 1, which is characterized in that institute The preparation process for stating thyroid peroxidase label sheep anti mouse antiantibody includes: by marker enzyme thyroid peroxidase and sheep Anti- mouse antiantibody is coupled to obtain thyroid peroxidase label sheep anti mouse antiantibody using Euplotes woodruffi.
CN201811496858.6A 2018-12-07 2018-12-07 The detection method of fluoquinolone constituents in a kind of fresh royal jelly Pending CN109633147A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811496858.6A CN109633147A (en) 2018-12-07 2018-12-07 The detection method of fluoquinolone constituents in a kind of fresh royal jelly

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811496858.6A CN109633147A (en) 2018-12-07 2018-12-07 The detection method of fluoquinolone constituents in a kind of fresh royal jelly

Publications (1)

Publication Number Publication Date
CN109633147A true CN109633147A (en) 2019-04-16

Family

ID=66072124

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811496858.6A Pending CN109633147A (en) 2018-12-07 2018-12-07 The detection method of fluoquinolone constituents in a kind of fresh royal jelly

Country Status (1)

Country Link
CN (1) CN109633147A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1766632A (en) * 2005-11-03 2006-05-03 北京望尔生物技术有限公司 ELISA kit for detecting quinolones in animal derived food
CN102766212A (en) * 2012-05-31 2012-11-07 华中农业大学 Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting residues of fluoroquinolones
CN103257233A (en) * 2013-05-31 2013-08-21 南京祥中生物科技有限公司 Biochip and method capable of simultaneously visually detecting multiple antibiotics, illegal addition agents and biotoxins
CN103323594A (en) * 2012-03-22 2013-09-25 北京勤邦生物技术有限公司 Enzyme-linked immunoassay kit for detecting quinolone drugs in aquatic products and its application
US20150219678A1 (en) * 2012-07-04 2015-08-06 Beijing Kwinbon Biotechnology Co., Ltd Enzyme-linked immunosorbent assay kit for detecting dinitolmide and use thereof
CN104977406A (en) * 2014-04-03 2015-10-14 北京勤邦生物技术有限公司 Enzyme-linked immunoassay kit for detecting fluoroquinolone medicine and application of kit
CN106645728A (en) * 2016-11-09 2017-05-10 百奥森(江苏)食品安全科技有限公司 Detection kit for fluoroquinolones drugs in foods

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1766632A (en) * 2005-11-03 2006-05-03 北京望尔生物技术有限公司 ELISA kit for detecting quinolones in animal derived food
CN103323594A (en) * 2012-03-22 2013-09-25 北京勤邦生物技术有限公司 Enzyme-linked immunoassay kit for detecting quinolone drugs in aquatic products and its application
CN102766212A (en) * 2012-05-31 2012-11-07 华中农业大学 Monoclonal antibody, enzyme-linked immunosorbent assay method and kit for detecting residues of fluoroquinolones
US20150219678A1 (en) * 2012-07-04 2015-08-06 Beijing Kwinbon Biotechnology Co., Ltd Enzyme-linked immunosorbent assay kit for detecting dinitolmide and use thereof
CN103257233A (en) * 2013-05-31 2013-08-21 南京祥中生物科技有限公司 Biochip and method capable of simultaneously visually detecting multiple antibiotics, illegal addition agents and biotoxins
CN104977406A (en) * 2014-04-03 2015-10-14 北京勤邦生物技术有限公司 Enzyme-linked immunoassay kit for detecting fluoroquinolone medicine and application of kit
CN106645728A (en) * 2016-11-09 2017-05-10 百奥森(江苏)食品安全科技有限公司 Detection kit for fluoroquinolones drugs in foods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
任军主编: "《安徽省突发公共卫生事件处置技术方案》", 31 January 2008, 合肥:安徽科学技术出版社 *
张文文: "蜂王浆中类固醇激素化合物检测方法的开发和应用", 《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》 *

Similar Documents

Publication Publication Date Title
Yang et al. Bovine leukemia virus infection in cattle of China: association with reduced milk production and increased somatic cell score
Marin et al. Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS
Wycoff et al. Chromatographic microassay for cholesterol and cholesterol esters
Paulos et al. Excretion of β-phenethylamine is elevated in humans after profound stress
CN102002531B (en) Toxoplasma gondii detection kit and application thereof
Honegger et al. Volatile amines in brain
CN1811436A (en) Method for detecting Ennoxacin and its special enzyme-linked immune reagent kit
Barbeau et al. Biochemistry of Parkinson's disease
CN101021535A (en) Enzyme-linked immunalogical kit for detecting gentamicin medicine and method
Raper et al. SEXUAL HORMONES IN ACHLYA: IV. PROPERTIES OF HORMONE A OF ACHLYA BISEXUALIS
CN109633147A (en) The detection method of fluoquinolone constituents in a kind of fresh royal jelly
Long et al. Differential expression of skeletal muscle mitochondrial proteins in yak, dzo, and cattle: a proteomics-based study
CN105695624A (en) Rapid identification method for different species of crude heparin sodium
CN101575649B (en) Quick detection technology for H9 type avian influenza virus
Rutter et al. Studies on the soluble antigens of Clostridium oedematiens (Cl. novyi)
Szalkowski et al. Colorimetric determination of calcium pantothenate
CN100492009C (en) ELISA kit for detecting fluoromethylquinoline and detection method thereof
CN101371869B (en) Inhibitor originated from alpha-glucosidase of natto and preparation method thereof
Manara Identification and estimation of tritium-labeled reserpine in biological material by a combination of thin-layer chromatography and liquid-scintillation radioassay
CN113009050A (en) Detection method and application of quinolone compounds in dairy products
CN108866153A (en) A kind of Application of Sialic Acid Measurement kit and its measuring method
CN109358152B (en) Thin-layer chromatography detection method for amino acid impurities in L-2-amino-5-guanidino valeric acid raw material
Hess et al. Inhibition of hepatitis b virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine
CN112852942A (en) Application of long-chain non-coding RNA in preparation of liver injury biomarker
Holmes et al. Effects of human thyroid-stimulating hormone and immunoglobulins on adenylate cyclase activity and the accumulation of cyclic AMP in human thyroid membranes and slices

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190416

RJ01 Rejection of invention patent application after publication